SHZ · 300298.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:31 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Sinocare Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.94% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Sinocare Inc.’s forward annual dividend is CN¥0.22 per share, paid annual. The forward yield is 1.2% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Sinocare Inc.’s next earnings report is currently expected on Apr 16, 2027, with estimated earnings per share of CN¥0.19. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sinocare Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products. The company was founded in 2002 and is based in Changsha, the People’s Republic of China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:46 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥1.22B+17.27% vs estimate |
| Q1 2025 | Apr 29, 2025 | CN¥0.13 | CN¥1.04B-0.04% vs estimate |
|---|
| Q1 2025 | Apr 20, 2025 | CN¥0.13 | CN¥1.26B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥27.97+CN¥0.27 (+0.97%)
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.6% below the high.
CN¥16.28+CN¥0.20 (+1.24%)
Guangzhou Wondfo Biotech Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 38.08% below the high.
CN¥10.29+CN¥0.03 (+0.29%)
Beijing Wandong Medical Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.53% below the high.
CN¥12.02+CN¥0.28 (+2.39%)
Edan Instruments, Inc.’s quoted price sits in the lower half of its reported 52-week range, 28.45% below the high.
CN¥98.80-CN¥1.01 (-1.01%)
HOB Biotech Group Corp.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 54.47% below the high.
CN¥38.70+CN¥1.17 (+3.12%)
Hangzhou Biotest Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.09% below the high.
CN¥12.49+CN¥0.22 (+1.79%)
Guangdong Transtek Medical Electronics Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 36.08% below the high.
CN¥5.89-CN¥0.03 (-0.51%)
Shenzhen Bioeasy Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.78% below the high.
